Cirkulerende tumorceller kan muligvis benyttes som prognostisk og prædiktiv markør ved ventrikelcancer
Research output: Contribution to journal › Journal article › Research › peer-review
Cecilie Okholm, Morten Thorsteinsson, Michael Patrick Achiam
Despite chemotherapy and intended curative surgery, approximately 50% of patients with gastric cancer develop recurrence and eventually die of metastatic disease. The detection of circulating tumour cells (CTC) in peripheral blood is a promising prognostic and predictive marker. The most typically applied approaches to the detection of CTC are RT-PCR and immunological assays. Measurement of CTC in gastric cancer seems useful for predicting prognosis and monitoring response of chemotherapy. There is still no gold standard for CTC-detection in gastric cancer patients and larger studies are needed.
|Journal||Ugeskrift for Laeger|
|Number of pages||4|
|Publication status||Published - 4 Aug 2014|